Midgard Science

Labs / CDMO: development & manufacturing

AccurEdit Therapeutics

Suzhou, China · accuredit.com

GMP

On your own

Free. Their own form.

Contact AccurEdit Therapeutics directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

AccurEdit Therapeutics develops in vivo gene editing medicines for severe or life-threatening hereditary and acquired diseases. It is based in China and focuses on RNA synthesis, gene editing, and delivery technologies for product development and commercialization.

Their website has a general contact form; we send your quote request through it.

What they offer

  • RNA synthesis

    Synthesizes mRNAs and gRNAs at research or GMP grade.

  • Gene editing platform development

    Develops editors for the modification of DNA, RNA, and other genetic components.

  • gRNA design, screening, optimization, and validation

    Supports gRNA selection using independently developed algorithms.

  • Delivery technology development

    Develops LNP and polymer-based delivery technologies for liver and other organs.

  • In vivo gene editing therapy development

    Builds end-to-end in vivo gene editing products from early stage to product approval.

What they work on

Modalities
Small molecule, Antibody, ADC, mRNA, Cell therapy, Gene editing, LNP / formulation
Assays and studies
gRNA screening, gRNA optimization, gRNA validation
Scale and capacity
industry-scale platform
Therapeutic areas
ATTR, hereditary diseases, acquired diseases
Sites
Suzhou, China
Quality
ICH guidelines (product development from early stage till product approval)
Serves
China, US, worldwide
Founded
2001

Similar labs. Probiocdmo, PROGEN INC, Unchained Labs, Vaxcyte

Found in a contract services directory. Listing built from accuredit.com. Work here? Claim this listing.

AccurEdit Therapeutics · Midgard Science